Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
4.750
-0.490 (-9.35%)
Sep 15, 2025, 2:21 PM EDT - Market open
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $208.17 million as of September 15, 2025. Its market cap has decreased by -21.70% in one year.
Market Cap
208.17M
Enterprise Value
184.05M
1-Year Change
-21.70%
Ranking
Category
Stock Price
$4.75
Market Cap Chart
Since the IPO on February 9, 2021, Nyxoah's market cap has decreased from $506.14M to $208.17M, a decrease of -58.87%. That is a compound annual growth rate of -17.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 208.17M | -34.96% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | 7.71% |
| Feb 9, 2021 | 506.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |